Cita APA

Abrisqueta, P., González Barca, E., Ferrá, C., Ríos-Herranz, E., Fernández de la Mata, M., Delgado, J., . . . Bosch Albareda, F. (2024). Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL).

Citación estilo Chicago

Abrisqueta, Pau|||0000-0001-9625-7422, et al. Ibrutinib Followed By Ofatumumab Consolidation in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL). 2024.

Cita MLA

Abrisqueta, Pau|||0000-0001-9625-7422, et al. Ibrutinib Followed By Ofatumumab Consolidation in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL). 2024.